{
    "title": "Novo Nordisk says EMA raised safety signal on drugs including semaglutide",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12222425/Novo-Nordisk-says-EMA-raised-safety-signal-drugs-shares-fall.html",
    "date": "2023-06-22",
    "keywords": [
        "signal",
        "safety",
        "ema",
        "cancer",
        "semaglutide",
        "spokesperson",
        "use",
        "andersenlange",
        "sanofi",
        "medicine",
        "skydsgaard",
        "copenhagen",
        "nordisk",
        "request",
        "class",
        "risk",
        "april",
        "event",
        "novo",
        "drop",
        "share",
        "movement",
        "response",
        "june",
        "eus",
        "month",
        "obesity",
        "ozempic",
        "agency",
        "way",
        "cause",
        "assessment",
        "topic",
        "director",
        "gmt",
        "market",
        "outlet",
        "bt",
        "report",
        "statement",
        "causal",
        "association",
        "surveillance",
        "priority",
        "committee",
        "glucagonlike",
        "peptide1",
        "glp1",
        "receptor",
        "substance",
        "discussion",
        "publication",
        "study",
        "information",
        "firm",
        "emas",
        "july",
        "astrazeneca",
        "comment",
        "mention",
        "wegovys",
        "label",
        "wegovy",
        "patient",
        "family",
        "history",
        "concern",
        "thing",
        "analyst",
        "soren",
        "hansen",
        "reporting",
        "maggie",
        "fick",
        "editing",
        "alexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}